Global markets over the weekend fractured along two distinct fault lines: geopolitical instability in the Middle East driving energy prices higher, and a severe correction in the technology sector that spilled over from US equities into Asian markets. The US-Iran conflict reignited after weeks of relative calm, with Iran launching drones toward the Strait of Hormuz on June 6. CNN reported that the US intercepted at least 4 of these drones, a development that immediately reversed a prior decline in crude oil futures from a low of $89.30. This incident marked the inception of a new upward trajectory for energy prices, which recovered to an intraday open of $92.15 before escalating further.

The volatility intensified on the evening of June 7 when the Israeli military issued a warning regarding potential rocket retaliation following an air raid on Beirut. This threat pushed oil prices to a peak of $94.72 before a brief pullback, only to surge again around 1:30 on June 8. The market's reaction demonstrated a high degree of sensitivity to real-time geopolitical developments. Data compiled by Woofun AI indicates that less than an hour after the price spike, former President Trump appeared on Fox News to urge restraint, stating, 'I want to say to Iran — your missile launches have been enough, stop here.' This conciliatory remark caused oil prices to retrace to pre-news levels, highlighting the market's adeptness at pricing in and out of short-term geopolitical noise.

Concurrently, the technology sector faced a severe liquidity event as the semiconductor sell-off that began in the US on Friday spread to AI-sensitive Asian markets upon Monday's opening. South Korea's KOSPI index suffered a midday plunge severe enough to trigger a circuit breaker, with industry giants Samsung Electronics and SK Hynix leading the decline. This panic selling raised critical questions regarding whether the market was prematurely pricing in the peak of the AI cycle or simply deleveraging crowded trades at elevated valuations. The sharp correction stood in stark contrast to the broader market's search for stability, suggesting a divergence in investor sentiment between speculative tech growth and tangible fundamentals.

Amidst the semiconductor turmoil, core industry players released signals intended to stabilize the narrative. On June 8, NVIDIA and SK Hynix announced a multi-year technology collaboration agreement to jointly develop next-generation memory products specifically for AI data centers. Hwang Ren-hong explicitly confirmed that SK Hynix would remain NVIDIA's largest memory partner, a statement that drove SK Hynix shares up 6.5% on TradeXYZ.

Furthermore, Hwang In-hyun's assertion that a memory shortage would persist for years caused a momentary spike in the DRAM ETF on TradeXYZ, pushing it to the weekend price boundary. Woofun AI notes that if NVIDIA believed AI infrastructure construction was nearing completion, there would be no strategic imperative to lock in long-term memory supply at this juncture, implying the sell-off may have been an overreaction to valuation concerns rather than a fundamental shift in demand.

In a market dominated by semiconductor weakness, the pharmaceutical sector emerged as a distinct haven for capital seeking certainty. Eli Lilly surged 8.64% over the weekend to reach $1,214.50, decoupling from the broader tech downturn. The catalyst for this rally was a report by TD Cowen, which raised its global GLP-1 market expectations for 2030 from $139 billion to $150 billion. The analysis projected that 59 million patients would receive GLP-1 therapy by that time, with oral weight-loss drugs expected to capture a 14% market share. The report further anticipated that Eli Lilly and Novo Nordisk would maintain their duopoly, holding 62% and 31% of the market share, respectively.

The performance of Eli Lilly underscored a broader strategic shift in fund allocation, where capital is increasingly rotating toward sectors with higher certainty of growth outside the volatile AI supply chain. While the semiconductor sector grappled with questions of cycle timing and valuation, the pharmaceutical leader demonstrated resilience based on robust fundamental forecasts. Woofun AI analysis suggests this divergence signals a maturing market dynamic where investors are selectively rewarding long-term revenue visibility over speculative momentum, potentially setting a precedent for future capital flows in an environment of mixed macroeconomic signals.